The Limited Times

Now you can see non-English news...

Covid: WHO homologous Chinese single-dose vaccine Convidecia

2022-05-19T12:45:48.321Z


The World Health Organization (WHO) today announced the emergency approval of the anti-Covid vaccine Convidecia from the Chinese laboratories CanSino Biologics. (HANDLE)


(ANSA) - GENEVA, MAY 19 - The World Health Organization (WHO) today announced the emergency approval of the anti-Covid vaccine Convidecia of the Chinese laboratories CanSinoBiologics.

The vaccine is based on a human-modified adenovirus, is administered in a single dose and the WHO recommends it for all ages starting from 18, according to a UN organization statement.

(HANDLE).


Source: ansa

All life articles on 2022-05-19

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.